These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36724833)

  • 1. Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolism.
    Ichida H; Fukami T; Kudo T; Mishiro K; Takano S; Nakano M; Morinaga G; Matsui A; Ishiguro N; Nakajima M
    Arch Biochem Biophys; 2023 Mar; 736():109536. PubMed ID: 36724833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.
    Matsumoto K; Hasegawa T; Ohara K; Takei C; Kamei T; Koyanagi J; Takahashi T; Akimoto M
    Xenobiotica; 2020 Jul; 50(7):783-792. PubMed ID: 31855101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: exploratory prediction using inhibitors and substrates as marker probes.
    Matsumoto K; Hasegawa T; Koyanagi J; Takahashi T; Akimoto M; Sugibayashi K
    Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):127-35. PubMed ID: 24659525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid
    Matsumoto K; Hasegawa T; Ohara K; Kamei T; Koyanagi J; Akimoto M
    Xenobiotica; 2021 Feb; 51(2):155-166. PubMed ID: 33146575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the Absolute Configuration of the Nabumetone Metabolite 4-(6-Methoxy-2-naphthyl)butan-2-ol Using the Chiral Derivatizing Agent, 1-Fluoroindan-1-carboxylic Acid.
    Kamei T; Kimura Y; Koyanagi J; Matsumoto K; Hasegawa T; Akimoto M; Takahashi T
    Chem Pharm Bull (Tokyo); 2019; 67(1):75-78. PubMed ID: 30606953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.
    Nobilis M; Mikušek J; Szotáková B; Jirásko R; Holčapek M; Chamseddin C; Jira T; Kučera R; Kuneš J; Pour M
    J Pharm Biomed Anal; 2013 Jun; 80():164-72. PubMed ID: 23584048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
    Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
    Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone.
    Matsumoto K; Nemoto E; Hasegawa T; Akimoto M; Sugibayashi K
    Biol Pharm Bull; 2011; 34(5):734-9. PubMed ID: 21532165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon-carbon bond cleavage in activation of the prodrug nabumetone.
    Varfaj F; Zulkifli SN; Park HG; Challinor VL; De Voss JJ; Ortiz de Montellano PR
    Drug Metab Dispos; 2014 May; 42(5):828-38. PubMed ID: 24584631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nabumetone: a "nonacidic" nonsteroidal antiinflammatory drug.
    Dahl SL
    Ann Pharmacother; 1993 Apr; 27(4):456-63. PubMed ID: 8477124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro.
    Skarydova L; Nobilis M; Wsól V
    Xenobiotica; 2013 Apr; 43(4):346-54. PubMed ID: 23020786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?
    Dandona P; Jeremy JY
    Drugs; 1990; 40 Suppl 5():16-24. PubMed ID: 2081487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
    Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota metabolizes nabumetone
    Jourova L; Anzenbacher P; Matuskova Z; Vecera R; Strojil J; Kolar M; Nobilis M; Hermanova P; Hudcovic T; Kozakova H; Kverka M; Anzenbacherova E
    Xenobiotica; 2019 Nov; 49(11):1296-1302. PubMed ID: 30794062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A photophysical and photochemical study of 6-methoxy-2-naphthylacetic acid, the major metabolite of the phototoxic nonsteroidal antiinflammatory drug nabumetone.
    Boscá F; Canudas N; Marín ML; Miranda MA
    Photochem Photobiol; 2000 Feb; 71(2):173-7. PubMed ID: 10687391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
    Melarange R; Spangler R; Hoult JR
    Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol.
    Lillibridge JA; Kalhorn TF; Slattery JT
    Drug Metab Dispos; 1996 Nov; 24(11):1174-9. PubMed ID: 8937849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hydroxysteroid (17β) Dehydrogenase Family Gene HSD17B12 Is Involved in the Prostaglandin Synthesis Pathway, the Ovarian Function, and Regulation of Fertility.
    Kemiläinen H; Adam M; Mäki-Jouppila J; Damdimopoulou P; Damdimopoulos AE; Kere J; Hovatta O; Laajala TD; Aittokallio T; Adamski J; Ryberg H; Ohlsson C; Strauss L; Poutanen M
    Endocrinology; 2016 Oct; 157(10):3719-3730. PubMed ID: 27490311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.